Naïve CD4+ T-Cells Predict CAR T Therapy Success
In the rapidly evolving landscape of cancer immunotherapy, chimeric antigen receptor T-cell (CAR T) therapy has emerged as a revolutionary approach, particularly in the treatment of large B-cell lymphoma (LBCL). Despite...
Read moreDetails























